Hubertus von Baumbach
Hubertus von Baumbach | |
|---|---|
| Born | 1966/1967 (age 53–54)[1] |
| Nationality | German |
| Education | Massachusetts Institute of Technology |
| Occupation | Businessman |
| Title | Chairman and CEO, Boehringer Ingelheim |
Hubertus von Baumbach (born 1967) is a German businessman who is the chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company.[2]
Early life and education[]
The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von Baumbach is also a great-grandson of the company's founder .[1] He has a law degree and an MBA from the Massachusetts Institute of Technology.[3][2]
Career[]
Baumbach joined Boehringer Ingelheim in 2001.[3]
In November 2015, it was announced that Baumbach, who had been CFO, was appointed as chief executive, succeeding in June 2016.[1][2] At the time, this made him the first member of the family at the helm in 25 years.[4] Within his first six months, he launched the biggest acquisition in the company’s history (an asset swap deal with French rival Sanofi), followed by a reorganization to give the group a more decentralized divisional structure.[5]
In his capacity at Boehringer Ingelheim, Baumbach was part of Chancellor Angela Merkel’s delegation on three state visits to China.[6]
Other activities[]
Corporate boards[]
- Deutsche Bank, Member of the Advisory Board[7]
- Baden-Württembergische Bank, Member of the Advisory Board
- Landesbank Baden-Württemberg (LBBW), Member of the Advisory Board[8]
- KWS Saat, Member of the Supervisory Board (2007-2017)
Non-profit organizations[]
- Federation of German Industries (BDI), Member of the Presidium (2018-2019)[9]
- German Chemical Industry Association (VCI), Member of the Executive Committee[10]
- Baden-Badener Unternehmer-Gespräche (BBUG), Member of the Board of Trustees[11]
- Cultural Foundation of the Federal States, Member of the Board of Trustees[12]
- Städel Museum, Member of the Administration[13] and the Board of Trustees[14]
- Stiftung Tausendgut, Member of the Board of Trustees[15]
References[]
- ^ Jump up to: a b c Editorial, Reuters. "Boehringer appoints first CEO from founding family in 25 years". reuters.com. Retrieved 7 November 2018.
- ^ Jump up to: a b c "Drug firm Boehringer Ingelheim on a high". handelsblatt.com. 27 April 2018. Retrieved 7 November 2018.
- ^ Jump up to: a b "Board of Managing Directors - boehringer-ingelheim.com". boehringer-ingelheim.com. Retrieved 7 November 2018.
- ^ Patricia Weiss and Maria Sheahan (November 6, 2015), Boehringer appoints first CEO from founding family in 25 years Reuters .
- ^ Siegfried Hofmann (April 27, 2018), Drug firm Boehringer Ingelheim on a high Handelsblatt .
- ^ Christian Schlesiger (September 8, 2017), Siemens-Chef Kaeser am häufigsten bei Delegationsreisen dabei Wirtschaftswoche.
- ^ Members of the Advisory Board, 2010 Deutsche Bank.
- ^ 2015 Annual Report Landesbank Baden-Württemberg (LBBW).
- ^ Presidium Federation of German Industries (BDI).
- ^ "Vorstand & Präsidium - Verband der Chemischen Industrie e.V. (VCI)". www.vci.de (in German). Retrieved 2017-06-01.
- ^ Board of Trustees Baden-Badener Unternehmer-Gespräche (BBUG).
- ^ Board of Trustees Cultural Foundation of the Federal States.
- ^ Administration Städel Museum.
- ^ Board of Trustees Städel Museum.
- ^ Board of Trustees Stiftung Tausendgut.
Authority control  |
|---|
 | This German business-related biographical article is a stub. You can help Wikipedia by . |
- 1960s births
- German chief executives
- MIT Sloan School of Management alumni
- Boehringer Ingelheim people
- Living people
- German business biography stubs